Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNA2 | P20248 | 9/20 | 1.00 |
| ▸ | CDK2 | P24941 | 9/20 | 1.00 |
| ▸ | CCND3 | P30281 | 14/20 | 0.80 |
| ▸ | CDK6 | Q00534 | 14/20 | 0.80 |
| ▸ | CCNK | O75909 | 13/20 | 0.80 |
| ▸ | CDK9 | P50750 | 13/20 | 0.80 |
| ▸ | CTSC | P53634 | 2/20 | 0.64 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30394643 | 0.89 | CCND3 (1.00) | CCNA2CDK2CCND3CDK6CCNK | |
| SCHEMBL30395234 | 0.88 | CCNA2 (1.00) | CCNA2CDK2CCND3CDK6CCNK | |
| SCHEMBL30394812 | 0.88 | CCNA2 (1.00) | CCNA2CDK2CCND3CDK6CCNK | |
| SCHEMBL30395002 | 0.86 | CCND3 (1.00) | CCNA2CDK2CCND3CDK6CCNK | |
| SCHEMBL30394979 | 0.86 | CCND3 (1.00) | CCNA2CDK2CCND3CDK6CCNK | |
| SCHEMBL30395254 | 0.78 | CCND3 (0.80) | CCNA2CDK2CCND3CDK6CCNK | |
| SCHEMBL24842795 | 0.78 | CTSC (1.00) | CCNA2CDK2CCND3CDK6CCNK | |
| SCHEMBL29816621 | 0.78 | CTSC (1.00) | CCNA2CDK2CCND3CDK6CCNK | |
| SCHEMBL23409097 | 0.77 | CCNA2 (1.00) | CCNA2CDK2CCND3CDK6CCNK | |
| SCHEMBL30394835 | 0.77 | CCNA2 (1.00) | CCNA2CDK2CCND3CDK6CCNK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111620852-B | 5-chloro-pyrimidine-2, 4-diamine compound, and preparation method and application thereof | 镇江植生源农业科技有限公司 | 2023-05-09 | — | — | CN | disclosed |